Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 6,399,000 | 5,945,000 | 6,307,000 | 6,057,000 | 6,716,000 |
| Cost of Goods | 1,269,000 | 1,041,000 | 1,067,000 | 1,269,000 | 1,667,000 |
| Gross Profit | 5,130,000 | 4,904,000 | 5,240,000 | 4,788,000 | 5,049,000 |
| Operating Expenses | 4,042,000 | 3,734,000 | 4,317,000 | 3,855,000 | 5,398,000 |
| Operating Income | 1,088,000 | 1,170,000 | 923,000 | 933,000 | -349,000 |
| Interest Expense | 292,000 | 246,000 | 276,000 | 261,000 | 261,000 |
| Other Income | 6,000 | 7,000 | 11,000 | 6,000 | 30,000 |
| Pre-tax Income | 802,000 | 931,000 | 658,000 | 678,000 | -580,000 |
| Income Tax | -6,000 | 161,000 | -38,000 | 126,000 | -259,000 |
| Net Income Continuous | 808,000 | 770,000 | 696,000 | 552,000 | -321,000 |
| Minority Interests | N/A | N/A | -1,000 | 2,000 | N/A |
| Net Income | $808,000 | $770,000 | $697,000 | $550,000 | $-321,000 |
| EPS Basic Total Ops | 0.32 | 0.30 | 0.28 | 0.22 | -0.13 |
| EPS Basic Continuous Ops | 0.32 | 0.30 | 0.28 | 0.22 | -0.13 |
| EPS Diluted Total Ops | 0.32 | 0.30 | 0.28 | 0.22 | -0.13 |
| EPS Diluted Continuous Ops | 0.32 | 0.30 | 0.28 | 0.22 | -0.13 |
| EBITDA(a) | $1,804,000 | $1,741,000 | $1,639,000 | $1,782,000 | $672,000 |